开拓现实世界的数据来应对肝细胞癌 - - 通过合并先的策略来解开可重复使用的药物
Gouri Nair1, Ganesan Rajalekshmi Saraswathy2, Prasanna Kumar Reddy Gayam3
1Department of Pharmacology, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India.
Journal of biomolecular structure & dynamics
|December 17, 2024
概括
这项研究使用现实世界数据和生物信息学重新定位了用于肝细胞癌 (HCC) 的现有药物. 阿洛普林醇通过降低关键癌症基因的调节和诱导肝癌细胞的亡,显示出有前途的结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 与新药发现相比,药物的重新用途加速了治疗的发展.
- 肝细胞癌 (HCC) 是一个重大挑战,需要创新的治疗策略.
研究的目的:
- 通过多方方法确定用于肝细胞癌 (HCC) 的可重复使用药物.
- 通过计算和实验方法验证潜在的候选药物.
主要方法:
- 利用来自FAERS的现实世界数据进行不成比例分析.
- 进行了转录基因分析以识别HCC目标 (例如,CCNA2/CDK2).
- 采用了分子对接,分子动力学模拟 (MDS) 和体外测试 (细胞毒性,基因表达).
主要成果:
- 从RWD.中确定了64种潜在的可重用药物.
- 通过in-silico分析确定了Allopurinol和Losartan是有前途的候选药物.
- 实验室研究证实了Allopurinol在降低CCNA2 / CDK2的有效性,并诱导HepG2细胞的亡.
结论:
- 现实世界数据对于有效的药物重用策略至关重要.
- 阿洛普林醇显示出作为HCC.重用治疗剂的显著潜力.
- 这项研究阐明了Allopurinol通过CCNA2/CDK2通路调节和亡诱导的抗癌机制.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


